RxDoctor Payments Data

Anthony Rodriguez

Family · Warren, ARNPI 1770020521

Payments from drug & device makers

$1,662in general payments, 2019–2025

Across 90 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$452
  • AbbVie$369
  • GSK$175
  • Merck$92
  • Pfizer$76
  • Novo Nordisk$68
  • plus $430 from 16 others

What the payments were for

  • Food & beverage$1,662100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,662 in reported general payments places this provider in the 75th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$13,542
Medicare patients
264
Services billed
699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin51$32,280
FarxigaDapagliflozin Propanediol41$20,863
OzempicSemaglutide17$16,622
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr26$13,439
EliquisApixaban14$9,716
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,992
PaxlovidNirmatrelvir/Ritonavir13$1,448
Albuterol Sulfate HfaAlbuterol Sulfate33$856
Gabapentin58$680
Duloxetine Hcl20$461
Losartan Potassium55$425
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst24$395
Omeprazole20$386
Pantoprazole Sodium39$379
Atorvastatin Calcium59$373

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$13$32,28051 claims
GSKAnoro Ellipta, Trelegy Ellipta$175$22,43140 claims
AstraZenecaFarxiga$452$20,86341 claims
Novo NordiskOzempic$68$16,62217 claims
PfizerEliquis, Paxlovid$76$11,16427 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,103 family providers in Arkansas.

Other family in Warren

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →